Sculley: Disruptive innovation shaping hospital M&A
Jun 22 | Jeff Lagasse
Sculley, who is now CMO of RxAdvance, weighs in on what the phase of big deals signal…
AMA comes out against CVS Health, Aetna merger
Jun 20 | Beth Jones Sanborn
AMA President Barbara McAneny says antitrust regulators have powerful reasons to block the…
AMA’s new policies take aim at drug shortages, poor EHR education
Jun 15 | Beth Jones Sanborn
One new policy deems drug shortages an urgent public health crisis and seeks to have manufacturing…
How pharma can boost revenue through adherence
Jun 14 | Jeff Lagasse
A more concerted effort by pharmaceutical companies to drive medication adherence could help them increase…
Azar: Government setting prices with big pharma won’t lower drug costs
Jun 13 | Susan Morse
Practice of PBMs being financially rewarded by drug manufacturers for setting higher prices…
Reducing opioid dosages raises patient satisfaction, study finds
Jun 08 | Jeff Lagasse
Kaiser Permanente found that hospitals can bolster patient satisfaction scores and increase revenue by…
Medicare Part D drug spending spikes 77%
Jun 05 | Beth Jones Sanborn
Even after taking into account manufacturer rebates, spending still increased more than 60 percent and the ranks of beneficiaries paying $2,000…
S&P: 340B cuts could further weaken struggling hospitals
Jun 04 | Beth Jones Sanborn
Program is a crucial part of operations for hospitals that serve vulnerable populations because it offsets the high costs…
FDA issues policies to stop blockage of generic drugs
May 31 | Susan Morse
Brand drug manufacturers are delaying the development and entry of generics, federal officials say.
Hospitals, payers, like Intermountain’s generic drug startup, payers not so much
May 29 | Beth Jones Sanborn
New research found that 90 percent of providers would purchase medications from the joint…